fighting malignant tumors tagged posts

Revealing a biological combat strategy worthy of a 5 star general, researchers show how a cell surface receptor can mobilize immune cells to attack, rather than protect, malignant tumors.In most cases, CD4+ T-cells in the immune system, commonly called CD4 or helper T-cells, scan the surface of foreign invaders within the body, including tumor cells, and send out chemical signals to mobilize killer T-cells–which then attack and destroy the threat. However, tumor cells often evade destruction by prompting immature T-cells to become regulatory T-cells, or Tregs. These cells are marked by a protein inside them, Foxp3+, which suppresses the ability of killer T-cells to attack tumors. Protected from the immune system, the tumor can grow unrestrained and spread cancer throughout the body.